Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
By
- AMS
posted
Sep 22, 2021 08:41 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Moderate-to-severe plaque psoriasis patients treated with ixekizumab: early real-world outcomes and adverse events
- AMS
Added Apr 22, 2020
Blog Entry
A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis
- AMS
Added Jun 28, 2021
Blog Entry
Should the presence of psoriatic arthritis change how we manage psoriasis?
- AMS
Added Nov 26, 2021
Blog Entry
Systemic treatment of psoriasis and psoriatic arthritis in the United States: a cross-sectional study
- AMS
Added Jul 27, 2020
Blog Entry
Disease response and patient-reported outcomes among initiators of ixekizumab
- AMS
Added Dec 03, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic